Curexo Inc. (060280.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	77.8B	74.5B	55.5B	72.9B	65.0B
Cost of Revenue	52.5B	52.5B	40.9B	53.6B	51.6B
Gross Profit	25.3B	22.1B	14.6B	19.3B	13.4B
Operating Expenses
R&D Expense	9.9B	9.1B	9.5B	7.6B	5.2B
SG&A Expense	7.0B	4.8B	4.7B	4.8B	3.0B
General & Admin Expense	2.3B	2.6B	2.2B	2.2B	1.4B
Selling & Marketing Expense	1.7B	2.2B	2.5B	2.6B	1.6B
Other Expenses	7.3B	5.8B	6.2B	5.8B	4.1B
Total Operating Expenses	21.3B	19.7B	20.4B	18.2B	12.3B
Cost and Expenses	74.5B	72.2B	61.4B	71.7B	63.9B
Operating Income (EBIT)	3.2B	2.4B	(5.8B)	1.1B	1.1B
Non-Operating
Interest Income	769.5M	930.4M	1.5B	1.3B	629.5M
Interest Expense	79.5M	87.4M	96.2M	414.2M	1.4B
Net Interest Income	690.0M	843.0M	1.4B	912.4M	(818.4M)
Other Non-Op Income/Expense	2.4B	469.3M	(2.8B)	(5.9B)	(4.0B)
Non-Operating Income (excl Interest)	(943.0M)	—	2.8B	5.5B	2.6B
EBT (Pre-Tax Income)	5.6B	2.8B	(8.7B)	(4.8B)	(2.9B)
Income Tax Expense	121.3M	59.3M	89.0M	96.1M	108.3M
Bottom Line
Net Income	5.5B	2.8B	(8.8B)	(4.9B)	(3.0B)
Earnings from Cont. Ops	5.5B	2.8B	(8.8B)	(4.9B)	(3.0B)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	5.5B	2.8B	(8.8B)	(4.9B)	(3.0B)
Per Share
Basic EPS	₩134	₩68	(₩213)	(₩120)	(₩84)
Diluted EPS	₩134	₩68	(₩213)	(₩120)	(₩84)
Revenue Per Share	₩1,884	₩1,814	₩1,352	₩1,801	₩1,795
Shares
Basic Shares Outstanding	41.3M	41.1M	41.1M	40.5M	36.2M
Diluted Shares Outstanding	41.3M	41.1M	41.1M	40.5M	36.2M
Profitability Metrics
EBITDA	1.2B	5.1B	(6.4B)	(2.8B)	(236.4M)
D&A	2.8B	2.8B	2.2B	1.6B	1.2B
EBIT	(1.5B)	2.4B	(8.6B)	(4.3B)	(1.5B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026